Tacrolimus versus ciclosporin in de novo paediatric heart transplant recipients

Trial Profile

Tacrolimus versus ciclosporin in de novo paediatric heart transplant recipients

Completed
Phase of Trial: Phase II

Latest Information Update: 17 May 2011

At a glance

  • Drugs Ciclosporin (Primary) ; Tacrolimus (Primary)
  • Indications Heart transplant rejection
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 17 May 2011 New trial record
    • 04 May 2011 Biomarker results presented at the American Transplant Congress -- 11th Joint Congress of the American Society of Transplant Surgeons and the American Society of Transplantation.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top